CA
NZ
UK
AU
IND
US
The release came at a delicate time. Global technology stocks fell sharply in early November on worries about AI regulation and a possible pause in data center spending after the US midterm elections, then rebounded on November 9 and 10. SoftBank shares closed nearly …
Key HighlightsMotorcar Parts of America (NASDAQ:MPAA) lowered its fiscal 2027 net sales outlook to USD 715 million to USD 740 million on November 9, 2026, from USD 780 million to USD 800 million.Fiscal second-quarter net sales fell to USD 169.2 million from USD 221.5 …
Because the measure is privileged, leaders must act on it within two legislative days, either by holding a vote or by moving to table or refer it. House Minority Leader Hakeem Jeffries has said he is a firm yes, and Democrats are widely expected …
Democrats won majorities in both chambers in the November 3 midterm elections, and at least 109 incoming House freshmen make up the largest such class in almost a century. At least 17 senators are leaving. On the Republican side, House Speaker Mike Johnson will …
Key HighlightsThryv Holdings (NASDAQ:THRY) reported a third-quarter 2026 net loss of USD 116.0 million, or USD 2.61 per diluted share, on November 9, including a USD 94.8 million non-cashGoodwillimpairment.ConsolidatedRevenuefell 13.5% to USD 118.9 million from USD 137.4 million and missed forecasts, as the print …
Key HighlightsUSA Rare Earth (NASDAQ:USAR) reported third-quarter 2026Revenueof USD 3.0 million on November 9, its first full quarter of commercial magnet sales, against no revenue a year earlier.The Serra Verde project in Brazil made its first commercial-scale shipments of mixed rare earth concentrate in …
Key HighlightsRepay Holdings (NASDAQ:RPAY) lowered its 2026 normalized organic growth outlook to 5% to 6% from 7% to 9% on November 9, 2026, excluding political media.Third-quarterRevenuerose 97% to USD 153.4 million, but KUBRA, acquired on June 1, 2026, contributed USD 65.1 million of that …
In chronic autoimmune diseases such as myasthenia gravis, patients may need treatment for years. A drug given every eight weeks under the skin, rather than weekly infusions or injections, would be a clear convenience advantage and could support adoption if efficacy is comparable. The …
Roivant's majority-owned Immunovant unit reported that a 600 milligram dose of IMVT-1402, an FcRn inhibitor, met the primary endpoint in a potentially registrational study in difficult-to-treat rheumatoid arthritis. At week 28, 92.5% of patients on that dose achieved an ACR20 response against 75.6% on …
The promotion is small in financial terms, but it speaks to a bigger issue. Comcast's broadbandBusinesshas faced intense competition from fixed wireless services offered by mobile carriers and from fiber builders, and the company has been working to slow customer losses. Free upgrades for …
Please wait processing your request...